AGE MANAGEMENT THERAPEUTICS
DEAD

Serial Number

78261650

Owner

Unifund Corporation

First Use Date

Apr 7, 2002

Filing Date

Jun 12, 2003

Add to watchlist:

No watchlists yet
View on USPTO

AGE MANAGEMENT THERAPEUTICS Trademark

Serial Number: 78261650 • Registration: 2888015

AGE MANAGEMENT THERAPEUTICS is a trademark filed by Unifund Corporation on June 12, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Unifund Corporation (23 trademarks)

10625 Techwoods Circle
Cincinnati, OH 45242

Entity Type: 03

Nathan Sassover

2770 LaCuesta Drive
Los Angeles, CA 90046

Entity Type: 01

UNIFUND CORPORATION LIMITED (5 trademarks)

BRUSHFIELD STREET
LONDON E1 6EU , GB

Entity Type: 13

Trademark Details

Filing Date

June 12, 2003

Registration Date

September 21, 2004

First Use Anywhere

April 7, 2002

First Use in Commerce

April 10, 2002

Cancellation Date

April 24, 2015

Goods & Services

Medicinal preparations, sold only by prescription, in the form of powders used as a neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer for the elimination of anxiety and hyperactivity, mitigation of panic symptomology, reduction of fatigue, improvement of self-confidence and self-esteem, elimination of the need for anti-depressants, cognitive enhancement, improvement of aerobic endurance and performance and weight-training capacity, improvement of blood circulation, reduction of blood pressure and hypertension, improvement of sexual performance and libido, reduction of hormonal imbalance in menopausal and post-menopausal women, improvement of visual and auditory acuity, improvement of physical agility and muscle flexibility, improvement of social interaction skills, promotion of relaxation response and mitigation of chronic sleep pattern disorders such as insomnia and other chronic sleep disorders, reduction of arthritic pain and swelling, enhancement of immune system functioning, improvement of the metabolism, relief from constipation, improvement of skin tone, mitigation of "jet lag," and reduction in caffeine dependence; and the treatment of a broad spectrum of conditions and pathologies, namely, age-related and neuro-degenerative conditions and pathologies, nerve diseases, general anxiety disorder, depression, neurosis, neurasthenia, obsessive-compulsive disorder, chronic sleep disorder, chronic fatigue syndrome, digestive diseases, chronic constipation, hypertension, osteoarthritis pain and swelling, and human sexual desire disorder

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Apr 24, 2015 CAEX
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 8, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 8, 2011 REAP
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Mar 10, 2010 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 10, 2010 APRE
TEAS SECTION 8 RECEIVED
Mar 3, 2010 ES8R
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 3, 2010 ASGN
REVIEW OF CORRESPONDENCE COMPLETE
Mar 21, 2006 CORV
PAPER RECEIVED
Jul 22, 2005 MAIL
SEC 7 REQUEST FILED
Nov 22, 2004 AMD7
PAPER RECEIVED
Nov 22, 2004 MAIL
REGISTERED-SUPPLEMENTAL REGISTER
Sep 21, 2004 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jul 14, 2004 CNTA
EXAMINERS AMENDMENT E-MAILED
Jul 14, 2004 GNEA
PAPER RECEIVED
Jun 29, 2004 MAIL
AMENDMENT FROM APPLICANT ENTERED
Jun 8, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2004 CRFA
PAPER RECEIVED
Jun 8, 2004 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 22, 2004 TCCA
NON-FINAL ACTION E-MAILED
Dec 18, 2003 GNRT
ASSIGNED TO EXAMINER
Dec 16, 2003 DOCK